US 11,925,804 B2
Multi-device obstructive sleep apnea (OSA) treatment
Jeffrey P. Bodner, Plymouth, MN (US); Avram Scheiner, Vadnais Heights, MN (US); Phillip C. Falkner, Minneapolis, MN (US); James Britton Hissong, Jacksonville, FL (US); Walton W. Baxter, III, San Clemente, CA (US); Richard T. Stone, Minneapolis, MN (US); Robert T. Sandgren, Lindstrom, MN (US); Ryan B. Sefkow, Plymouth, MN (US); and Adam J. Rivard, Blaine, MN (US)
Assigned to Medtronic Xomed, LLC, Jacksonville, FL (US)
Filed by Medtronic Xomed, LLC, Jacksonville, FL (US)
Filed on Nov. 3, 2021, as Appl. No. 17/453,474.
Prior Publication US 2023/0136535 A1, May 4, 2023
Int. Cl. A61N 1/36 (2006.01); A61N 1/05 (2006.01); A61N 1/372 (2006.01)
CPC A61N 1/3611 (2013.01) [A61N 1/0551 (2013.01); A61N 1/3601 (2013.01); A61N 1/36135 (2013.01); A61N 1/37288 (2013.01)] 21 Claims
OG exemplary drawing
 
1. A medical device for obstructive sleep apnea therapy, wherein the medical device is a first medical device implantable within a head or neck of a patient, and wherein the first medical device comprises:
therapy delivery circuitry coupled to a first set of electrodes implantable proximate to a first hypoglossal nerve within a tongue of the patient and configured to deliver a first electrical stimulation signal to the first hypoglossal nerve that causes the tongue of the patient to advance and includes information to communicate to a second medical device implantable within the head or neck of the patient and coupled to a second set of electrodes implantable proximate to a second hypoglossal nerve within the tongue of the patient; and
sensing circuitry coupled to the first set of electrodes and configured to receive a second electrical stimulation signal, delivered to the second hypoglossal nerve by the second medical device, that includes information that the second medical device communicates to the first medical device.